The therapeutic potential of stem cell-based therapies may be largely dependent on the ability of stem cells to modulate host cells rather than on their differentiation into host tissues. Within the last decade, there has been considerable interest in the inter-cellular communication mediated by the transfer of cytoplasmic material and organelles between cells. Numerous studies have shown that mitochondria and lysosomes are transported between cells by various mechanisms, such as tunnelling nanotubes, microvesicles and cellular fusion. This review will focus on the known instances of organelle transfer between stem cells and differentiated cells, what effects it has on recipient cells and how organelle transfer is regulated.
Introduction
Previous research has provided convincing evidence that stem cell-based therapies hold great therapeutic potential for many diseases (1) . While their mechanisms of action are still under investigation, the therapeutic influence of stem cells may be largely dependent on their modulation of host cells rather than their differentiation in host tissues as they have relatively poor survival and engraftment following transplantation. Therefore, attention has now focused on examining the intercellular interactions underlying stem cell effects and the role of their secretome in cell-to-cell communication.
Intercellular communication is vital for all biological processes, including the maintenance of tissue homeostasis, regulation of normal cellular function and response to external environmental signals that impact cell survival. Cells continuously interact with each other and have the capacity to connect with both contiguous and distant cells through a wide range of communication networks, such as: paracrine signalling, transport through gap junctions and electrical coupling, tunnelling nanotubes and extracellular vesicle secretion. Within the last decade, there has been considerable interest in the different types of cell-to-cell interaction which include the transfer of cytoplasmic material and organelles between cells which will be the main focus of this review. We will discuss the major mechanisms of stem cell-mediated organelle transfer, the consequences of such transfer to recipient cells and how organelle transfer is regulated. The majority of information on stem cell-mediated organelle transfer has arisen from studies investigating the mechanisms of mesenchymal stem cell (MSC) therapeutic efficacy with only a small proportion of studies describing organelle transfer from other stem cell types. Table 1 summarises existing studies on intercellular organelle transfer between different types of stem cells and differentiated cells in various disease models.
Mechanisms of Organelle Transfer
Organelle exchange between cells can occur via three potential means: tunnelling nanotubes (TNTs), extracellular vesicles (EVs) and cellular fusion. (2) . Formation of these tubular structures has mainly been identified in in vitro co-culture systems between various cell types, including: stem, immune (monocytes, macrophages and neutrophils), neuronal and cancer cells (3) . In vivo, TNT-like structures, termed cytonemes, were reported to be involved in signal transduction during the imaginal disc development of Drosophila (4, 5) and during reproduction of Plasmodium in the Anopheles malaria midgut (6) . TNTs also mediate intercellular communication between immune cells in the lymph nodes (see review by (3, 7, 8) and between dendritic cells in mouse cornea (9) . Furthermore, TNT-like structures were observed in human malignant tumours (10) (11) (12) (13) (14) as well as between cardiomyocytes and nonmyocytic cells in the heart (15) .
TNT biogenesis is not yet fully understood but a number of components are thought to be involved in their formation. It is known that TNTs contain an array of cytoskeletal filaments of which F-actin is the most abundant (2). In addition, microtubules can also exist in TNTs of specific cell types, such as immune cells (16) , astrocytes and primary neuronal cells, which form much thicker nanotubules (17) .
Bukoreshtliev and colleagues reported that nanotubules are formed by extension and retraction of filopodia that physically make contact with and connect contiguous cells (18) .
TNT-mediated cell contact results in the transfer of intracellular content between communicating cells. The presence of several motor proteins, like calcium-sensitive dynamin related Rho-GTPases Miro1 and Miro2 (19, 20) , KLF 5 kinesin motor protein (21) and accessory proteins like TRAK 1 and TRAK 2 (22, 23) , Myo 19 and Myo 10 (24) permit the efficient shipping of cargo between cells via an actin-myosin-dependent mechanism (25) . Transported cargo includes large organelles, like mitochondria (26) (27) (28) (29) (30) and smaller membranous vesicles of the endocytic pathway, such as lysosomes, which are typically transported bi-directionally (31, 32) . Once the tubule protrudes from the donor cell's plasma membrane, it makes contact and fuses with the recipient's plasma membrane allowing organelle deposition into the cytosol (2) . However, it is not clear yet if the fusion process is specific and requires some recognition event or if it occurs spontaneously. Liu et al demonstrated that establishment of TNTs between MSCs and oxidative stress-injured endothelial cells (HUVECs) required recognition of the surface-exposed phosphatidylserines (PSs) on the injured HUVECs by MSCs. Shielding of PSs with Annexin V resulted in the failure of TNT-mediated cell contact between the two cell types (29) . Additionally, TNTs were shown to be responsible for the transmission of electrical signals between kidney cells (33) as well as calcium signalling between dendritic and monocyte cells (34) , reflecting the multifaceted nature of TNTs in normal cellular functioning.
Many environmental cues are known to induce TNT development between cells, such as hydrogen peroxide, serum starvation (35) and cytokines (36) . Wang et al demonstrated that TNT formation in astrocytes and neurons involved p53, EGFR, Akt, PI3K and mTOR activation (35) . They also showed that it is the stressed cells that always develop TNTs which extend to the unstressed cells but whether or not these findings are applicable to other cell types requires further investigation.
In the pioneering work of Rustom et al, it was shown that TNTs actively transfer vesicles positive for markers of the endosomal/lysosomal system and plasma membrane components but do not transfer soluble cytoplasmic proteins (2) .
Koyangi et al were the first to report that TNTs are also capable of transferring mitochondria from cardiomyocytes to human endothelial progenitor cells in co-culture (37) . Since then, numerous studies have demonstrated that MSCs utilise TNTs to transfer mitochondria to various cell types. Similarly, TNT-mediated transport of lysosomes from early progenitor cells to injured or stressed endothelial cells results in the reconstitution of the lysosomal pool which attenuates premature cell senescence and tension of blood vessels through increased vaso-relaxation (38) (Figure 1 A) .
In addition to the transfer of organelles, TNTs are also involved in the transport of cytoplasmic content (26, (39) (40) (41) . With regards to stem cells, transfer of cytoplasmic content from differentiated cells was associated with MSC differentiatiation towards cardiomyocytes (39) or renal tubular cells (26) but not neurons (41) . In these studies, it was observed that transport of cytoplasmic contents was predominantly directed 
Extracellular Vesicles
Organelle transfer between cells can also occur through their secretion in extracellular vesicles (EVs). This is an umbrella term used to describe a heterogeneous group of biologically active membrane-encompassed vesicles released by cells (42, 43) . EVs are found in numerous bodily fluids, including: urine, plasma, whole-blood as well as in vitro culture medium. They can carry lipids, proteins, enzymes, coding and non-coding RNA molecules. Upon interaction with their target cells, EVs can be internalised and their cargo released inside the recipient cell(s). Therefore, EVs act as envoys for long-distance cross-talk between cells (44) (45) (46) and are capable of heavily influencing target cell function (47) . To date, documented evidence of organelle transfer in EVs only exists for mitochondria but it is plausible to suggest that ribosomes and lysosome-like structures may also be transported. According to their size and biogenesis, EVs can be categorised into three main subtypes: exosomes, microvesicles and apoptotic bodies (48, 49) .
 Exosomes are small homogenous membrane-coated vesicles ranging from 30-100 nm in diameter (50, 51) . They are generated from the late endosomal pathway. During endosome maturation, parts of the endosomal outer membrane bud inside as intraluminal vesicles forming multivesicular bodies (MVBs) (50,51) MVBs subsequently move to and fuse with the plasma membrane of the cell leading to the extrusion of exosomes into the surrounding extracellular environment (52,53) Exosome release is typically regulated by activation of the cell cytoskeleton but not the influx of calcium (54, 55) . Exosomes are known to contain a multitude of endosomal markers, such as CD9 and CD63 as well as some heat-shock proteins, including Hsp90, Hsp60 and Hsp70. They also carry a variety of molecular cargo, like proteins (56, 57) and genetic components, such as messenger and microRNAs (58) . Due to their small size, it is unlikely that exosomes could carry larger organelles, like mitochondria. On the contrary, they may transfer organelle fragments (such as protein complexes of the mitochondrial electron transfer chain) and ribosomes.
Interaction with target cells can be achieved through receptor-ligand signalling (59) . It has been suggested that integrins may play a vital role in the homing of exosomes to endothelial cells, which express the VCAM-1 integrin receptor, or cardiomyocytes which express ICAM-1 following myocardial ischaemiareperfusion injury (60) . Additionally, tetraspanin proteins could assist in the uptake of exosomes as these are primarily involved in invasion and fusion events within cells (61) . Other likely means of exosomal internalisation by cells include: endocytosis, phagocytosis and membrane fusion (59) .
 Microvesicles are heterogeneous structures that are formed by the protrusion, external budding and fission of the cell's plasma membrane which subsequently liberates spherical structures, containing cargo, into the extracellular space (62) . They are the largest of the three vesicle types, ranging from 50-1000 nm in diameter (51) but can also reach sizes up to 10 µM in the case of cancer cells were they are commonly referred to as oncosomes (62) . One of the best known mechanisms of microvesicle biogenesis is the recruitment of TSG101 protein to the cell surface by arrestin domain-containing protein 1 (ARRDC1). Unlike MVB-derived exosomes, ARRDC1-mediated microvesicles (ARMMs) do not express late endosomal markers. Formation and release of arrestin domain-containing protein 1mediated microvesicles (ARMMs) at the plasma membrane is mediated by the recruitment of TSG101 protein (63) . Microvesicle biogenesis is influenced by both intracellular calcium concentrations and cytoskeleton activation. Like exosomes, they transport lipids, proteins, mRNAs and microRNAs and also communicate with their cellular target through receptor-ligand interactions, phagocytosis, membrane contact and endocytic pathways (59) . Cargo sorting and microvesicle shedding are regulated by small GTPases, including members of the ARF, Rab and Rho families (reviewed in (62)).
Islam et al were the first group to report the phenomenon of EV-mediated mitochondrial transfer from MSCs to lung alveolar epithelial cells (28) , followed by the elegant study by Phinney and colleagues which demonstrated that MSCderived EVs contained functional mitochondria which were subsequently internalised by macrophages and as a result, enhanced their levels of oxidative phosphorylation.
Simultaneously, shedding of exosomes from MSCs regulated toll-like receptor signalling and cytokine production through the transfer of regulatory microRNAs, particularly miR-451 (64) . According to their study, mitochondria-containing EVs were positive for microtubule-associated protein 1 light chain 3 (LC3) and autophagy-related protein 12 which are characteristic of autophagosomes. These EVs also expressed the endosomal sorting complex required for transport (ESCRT) TSG101 and ARRDC1, suggesting that their biogenesis was mediated through the microvesicle formation pathway (64) (Figure 1B) . Besides mitochondria, EVs can also transfer ribosomes. It was previously demonstrated by Court and colleagues that shwann cells use EVs to transfer polyribosomes to axons (65) . Although no reports have yet identified the presence of ribosomes in EVs originating from stem cells, this could be a potential mechanism for modifying gene expression and protein production within recipient cells. Recently, other mechanisms of EV formation during apoptosis have been reported.
Apoptotic T cells were found to form fine protusions, termed 'apoptopodia' that appear to be involved in the release of EVs greater than 1 µm (67). EV production from late stage apoptotic monocytes but not neuronal cells, squamous epithelial cells and cervical epithelial cells has been observed to involve fragmentation of membrane protrusions resembling 'beads on a string' (68) . While the significance of these observations remains to be fully elucidated, EVs produced from fragmentation of beaded apoptopodia were found to be enriched in mitochondria and acidic organelles but devoid of nuclear components, including histones and DNA (68) and GATA-4, indicating a potential regenerative mechanism whereby cardiomyocytes regain their proliferative and survival properties to repair damaged heart tissue (27) . The authors further noted that restoration of cardiomyocyte function and survival was facilitated by the transfer and persistence of stem cell mitochondria within distressed heart cells (Figure 1 C) .
Mitochondrial transfer
Accumulating evidence now suggests that MSCs transport mitochondria to numerous cell types, including: endothelial, epithelial, cardiac, renal, corneal and immune cells, particularly under conditions of stress or injury (Figure 1) . Islam MSCs under oxidative stress conditions (64) . We have also demonstrated mitochondrial transfer from MSCs to macrophages via TNTs which resulted in the enhancement of macrophage bioenergetics and improvement of their phagocytic activity both in in vitro and in vivo models of Escherichia-coli-induced lung injury (30) .
Interestingly in this study, we found that when TNTs were blocked by Cytochalasin B, mitochondrial transfer to macrophages still occurred via EV secretion, suggesting that both mechanisms act simultaneously. In a subsequent study, we have found that mitochondrial transfer in MSC EVs augmented levels of oxidative phosphorylation in macrophages, resulting in their metabolic reprogramming from a pro-inflammatory towards an anti-inflammatory phenotype with enhanced phagocytic activity (76) .
Numerous studies have reported mitochondrial transfer directed from MSCs to cardiomyocytes (27, 36, 39, 77) Jiang and authors reported that MSC-mediated mitochondrial transfer rescued corneal epithelial cells from Rotenone (Rot)-induced oxidative stress which was further detected in their in vivo rabbit model of alkali eye injury. Notably, in this study, MSCs with impaired mitochondrial function were not able to improve corneal epithelial cell wound healing in vivo (78) .
Unidirectional TNT-mediated transfer of mitochondria between MSCs and neural cells and astrocytes was detected in vitro and confirmed in rat brains in vivo (41) . In this study, rat brains were injected with mitoGFP-expressing MSCs. Interestingly, GFP-positive particles were found in the cellular bodies of neurons in rat brain slices.
Consequences of mitochondrial transfer to recipient cells
At present, the majority of studies suggest that transfer of functional mitochondria results in the improvement of mitochondrial respiration, ATP production and/or mitigation of mitochondrial ROS levels in recipient cells leading to improved functional activity (e.g. surfactant secretion, phagocytosis and wound healing) and viability ( Table 1 ). In addition, there is evidence alluding to the involvement of mitochondrial transfer in shaping the nuclear transcriptional landscape and contributing to cellular reprogramming. Acquistapace et al revealed that MSC mitochondria were responsible for reprogramming cardiomyocytes towards earlier progenitors (27) . Zhao and collaborators showed that platelets were modulated in diabetic patients who received a novel type of stem cell educator therapy. This technique utilised autologous patient lymphocytes which were briefly exposed to adherent stem cells from cord blood in the therapy device (79) . Treatment with a single dose of this therapy caused permanent reversal of T cell autoimmunity, regeneration of pancreatic islet β cells and improved metabolic control in patients with diabetes. The authors discovered that after interaction with cord blood stem cells, platelets exhibited immune-tolerance markers, such as autoimmune regulator (AIRE) which could alter immune cell function and proliferation. Human cord-and peripheral blood-derived platelets were also found to express embryonic stem cell markers (OCT4, SOX2, KLF4, and C-MYC), specific human islet B-cell transcription factor MAFA and the pancreatic progenitor-associated marker SOX9. Remarkably, all of these markers were associated with the platelets' mitochondria. Co-culture of cord blood-derived platelets with human islet cells resulted in platelet mitochondrial uptake and improved islet cell viability, proliferation and increases C-peptide release in vitro. Furthermore, migration of platelets into pancreatic islets was demonstrated immunohistochemically on biopsies from diabetic subjects. The authors hypothesized that migration of platelets to the pancreas and transfer of mitochondria to pancreatic islet cells were responsible for β-cell neogenesis and long-term clinical improvements in the diabetic patients observed in this trial (79) . This is the first report directly demonstrating a key role of mitochondria in tissue regeneration, possibly through the transfer of stemness factors.
However, mitochondrial transfer does not always have beneficial effects. Stem cells have the capacity to deliver functional mitochondria to opportunistic cancer cells which could be detrimental as this may optimise or restore tumor dysfunctional metabolic machinery (80, 81, (97) (98) (99) (100) . Tumours devoid of mitochondrial DNA can obtain new DNA from surrounding stromal cells via TNT formation so that respiratory function is re-established for further tumour initiation and even dissemination. This has been observed in acute myeloid leukaemia where MSC mitochondrial transfer confers resistance to chemotherapy treatment (80) . By contrast, some reports have noted that increased mitochondrial transfer from MSCs to malignant cells actually perturbs their proliferative and invasive potential so the role of mitochondria in cancer remains ambiguous (81) . MSCs to donate more mitochondria (84) . Similarly, mitochondrial transfer from MSCs to astrocytes was more efficient when recipient cells were exposed to ischemic damage associated with elevated ROS levels (85) .
Ahmad at al were the first to demonstrate that over-expression of the Miro-1 protein (mitochondrial Rho-GTPase1 that regulates intercellular mitochondrial movement) in MSCs, enhances efficiency of transfer to bronchial epithelial cells and results in better therapeutic effect in mouse models of Rot-induced airway injury and allergic airway inflammation (19) . Furthermore, it was demonstrated that Miro-1 overexpression improves MSC therapeutic efficacy in models of cardiomyopathy (36) and ischemic stroke in rats (85) . What still remains a mystery is the degree of damage required to incite stem cellmediated mitochondrial transfer. It is possible that injured cells can resolve their own endogenous organelle network before relying on exogenous sources for recovery but the mechanisms governing this are elusive. Our unpublished observations suggest that mitochondrial transfer from MSCs to recipient cells occurs at a substantial level without any injurious stimuli and is not selective in regard to recipient cell type.
However, in the presence of stimulation (inflammatory or oxidative stress), the uptake of MSC mitochondria is significantly enhanced. Another important question that pertains is the fate of exogenous mitochondria once delivered to recipient cells.
It is well established that stem cells utilise glycolysis for their energy needs and switch to oxidative phosphorylation only upon differentiation. Their mitochondria are largely in a dormant state as reflected by their shape (round, undefined cristae), cellular localisation (cytosolic) and number (scarce) as opposed to the mitochondria in cells with higher energetic demands (elongated in shape with well defined cristae and prenuclear localisation) (86) . Apparently upon transfer to the recipient cell, these dormant stem cell-derived mitochondria undergo functional and morphological remodelling similar to that observed during differentiation. Here, an increase in mtDNA copy number, enhanced oxygen consumption rate and increased levels of On the contrary, MSC nuclear DNA was not detected after 3 days post administration, suggesting that mitochondrial transfer is sustainable and might at least partially explain the long-term therapeutic effects seen after MSC administration (64) .
Lysosomal Transfer
Lysosomes are highly dynamic membrane-bound structures that are about 50-500 nm in diameter and are responsible for the internalisation of extracellular material from either endocytosis or phagocytosis as well as intracellular constituents from autophagy (90) . Because these organelles contain over 60 potent hydrolytic enzymes together with a highly acidic microenvironment, they also participate in the subsequent degradation of cargo (90, 91) 
